STRATEC Biomedical AG 

29.10.2014 17:51

Dissemination of a Voting Rights Announcement, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

---

1. Ameriprise Financial, Inc.

Ameriprise Financial, Inc., Minneapolis, Minnesota, USA, has notified us pursuant to sec. 21 para. 1 WpHG on 24 October 2014, that on 21 October 2014 the share of voting rights in STRATEC Biomedical AG, Birkenfeld, Germany, ISIN: DE0007289001 went below the threshold of 5% and that the percentage of voting rights on that day amounted to 4.99% (588,319 voting rights). Ameriprise Financial, Inc. has notified us that these voting rights of 4.99% (588,319 voting rights) are attributable to Ameriprise Financial, Inc. pursuant to sec. 22 para. 1 sent. 1 no. 6 in connection with sent. 2 WpHG.

The voting rights were attributed to Ameriprise Financial, Inc. inter alia from Threadneedle Investment Funds ICVC, being a shareholder holding 3% or more of the voting rights in STRATEC Biomedical AG.

2. Threadneedle Asset Management Holdings SARL

Threadneedle Asset Management Holdings SARL, Luxembourg, Luxembourg, has notified us pursuant to sec. 21 para. 1 WpHG on 24 October 2014, that on 21 October 2014 the share of voting rights in STRATEC Biomedical AG, Birkenfeld, Germany, ISIN: DE0007289001 went below the threshold of 5% and that the percentage of voting rights on that day amounted to 4.99% (588,319 voting rights). Threadneedle Asset Management Holdings SARL has notified us that these voting rights of 4.99% (588,319 voting rights) are attributable to Threadneedle Asset Management Holdings SARL pursuant to sec. 22 para. 1 sent. 1 no. 6 in connection with sent. 2 WpHG.

The voting rights were attributed to Threadneedle Asset Management Holdings SARL inter alia from Threadneedle Investment Funds ICVC, being a shareholder holding 3% or more of the voting rights in STRATEC Biomedical AG.


3. Threadneedle Holdings Limited

Threadneedle Holdings Limited, London, UK, has notified us pursuant to sec. 21 para. 1 WpHG on 24 October 2014, that on 21 October 2014 the share of voting rights in STRATEC Biomedical AG, Birkenfeld, Germany, ISIN: DE0007289001 went below the threshold of 5% and that the percentage of voting rights on that day amounted to 4.99% (588,319 voting rights). Threadneedle Holdings Limited has notified us that these voting rights of 4.99% (588,319 voting rights) are attributable to Threadneedle Holdings Limited pursuant to sec. 22 para. 1 sent. 1 no. 6 in connection with sent. 2 WpHG.

The voting rights were attributed to Threadneedle Holdings Limited inter alia from Threadneedle Investment Funds ICVC, being a shareholder holding 3% or more of the voting rights in STRATEC Biomedical AG.

4. TAM UK Holdings Limited

TAM UK Holdings Limited, London, UK, has notified us pursuant to sec. 21 para. 1 WpHG on 24 October 2014, that on 21 October 2014 the share of voting rights in STRATEC Biomedical AG, Birkenfeld, Germany, ISIN: DE0007289001 went below the threshold of 5% and that the percentage of voting rights on that day amounted to 4.99% (588,319 voting rights). TAM UK Holdings Limited has notified us that these voting rights of 4.99% (588,319 voting rights) are attributable to TAM UK Holdings Limited pursuant to sec. 22 para. 1 sent. 1 no. 6 in connection with sent. 2 WpHG.
The voting rights were attributed to TAM UK Holdings Limited inter alia from Threadneedle Investment Funds ICVC, being a shareholder holding 3% or more of the voting rights in STRATEC Biomedical AG.

5. Threadneedle Asset Management Holdings Limited

Threadneedle Asset Management Holdings Limited, London, UK, has notified us pursuant to sec. 21 para. 1 WpHG on 24 October 2014, that on 21 October 2014 the share of voting rights in STRATEC Biomedical AG, Birkenfeld, Germany, ISIN: DE0007289001 went below the threshold of 5% and that the percentage of voting rights on that day amounted to 4.99% (588,319 voting rights). Threadneedle Asset Management Holdings Limited has notified us that these voting rights of 4.99% (588,319 voting rights) are attributable to Threadneedle Asset Management Holdings Limited pursuant to sec. 22 para. 1 sent. 1 no. 6 in connection with sent. 2 WpHG.

The voting rights were attributed to Threadneedle Asset Management Holdings Limited inter alia from Threadneedle Investment Funds ICVC, being a shareholder holding 3% or more of the voting rights in STRATEC Biomedical AG.


6. TC Financing Limited

TC Financing Limited, London, UK, has notified us pursuant to sec. 21 para. 1 WpHG on 24 October 2014, that on 21 October 2014 the share of voting rights in STRATEC Biomedical AG, Birkenfeld, Germany, ISIN: DE0007289001 went below the threshold of 5% and that the percentage of voting rights on that day amounted to 4.99% (588,319 voting rights). TC Financing Limited has notified us that these voting rights of 4.99% (588,319 voting rights) are attributable to TC Financing Limited pursuant to sec. 22 para. 1 sent. 1 no. 6 in connection with sent. 2 WpHG.

The voting rights were attributed to TC Financing Limited inter alia from Threadneedle Investment Funds ICVC, being a shareholder holding 3% or more of the voting rights in STRATEC Biomedical AG.


7. Threadneedle Asset Management Limited

Threadneedle Asset Management Limited, London, UK, has notified us pursuant to sec. 21 para. 1 WpHG on 24 October 2014, that on 21 October 2014 the share of voting rights in STRATEC Biomedical AG, Birkenfeld, Germany, ISIN: DE0007289001 went below the threshold of 5% and that the percentage of voting rights on that day amounted to 4.99% (588,319 voting rights). Threadneedle Asset Management Limited has notified us that these voting rights of 4.99% (588,319 voting rights) are attributable to Threadneedle Asset Management Limited pursuant to sec. 22 para. 1 sent. 1 no. 6 WpHG.
The voting rights were attributed to Threadneedle Asset Management Limited inter alia from Threadneedle Investment Funds ICVC, being a shareholder holding 3% or more of the voting rights in STRATEC Biomedical AG.


29.10.2014 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---

 
Language:     English
Company:      STRATEC Biomedical AG
              Gewerbestr. 37
              75217 Birkenfeld
              Germany
Internet:     www.stratec.com
 
End of Announcement DGAP News-Service  

---